Kaplan Johanne 4
4 · ProMIS Neurosciences Inc. · Filed Nov 20, 2024
Insider Transaction Report
Form 4
Kaplan Johanne
Chief Development Officer
Transactions
- Award
Option (right to buy)
2024-11-18+175,000→ 175,000 totalExercise: $1.00Exp: 2034-11-18→ Common Shares (175,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest on November 18, 2025, and the balance shall vest ratably over 36 months.